{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "23", "@timestamp": "2021-02-23T17:24:20.000020-05:00", "@year": "2021", "@month": "02"}, "ait:date-sort": {"@day": "13", "@year": "2017", "@month": "01"}}, "xocs:meta": {"xocs:funding-list": {"@pui-match": "primary", "@has-funding-info": "1", "xocs:funding": [{"xocs:funding-agency-matched-string": "Chulalongkorn Academic Advancement"}, {"xocs:funding-agency-matched-string": "Chulalongkorn University Ratchadaphiseksomphot Fund"}], "xocs:funding-addon-generated-timestamp": "2021-09-16T14:40:14.342730Z", "xocs:funding-text": "Luca Cannizzaro is a recipient of the Post-Doctoral Scholarship, Chulalongkorn University Ratchadaphiseksomphot Fund and was also supported by the Chulalongkorn Academic Advancement into Its 2nd Century Project.", "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"country": "Thailand", "postal-code": "10330", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Systems Biology Center"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "115138551"}, "@dptid": "115138551"}, "author": [{"ce:given-name": "Luca", "preferred-name": {"ce:given-name": "Luca", "ce:initials": "L.", "ce:surname": "Cannizzaro", "ce:indexed-name": "Cannizzaro L."}, "@seq": "1", "ce:initials": "L.", "@_fa": "true", "@type": "auth", "ce:surname": "Cannizzaro", "@auid": "56809020400", "ce:indexed-name": "Cannizzaro L."}, {"ce:given-name": "Thammakorn", "preferred-name": {"ce:given-name": "Thammakorn", "ce:initials": "T.", "ce:surname": "Saethang", "ce:indexed-name": "Saethang T."}, "@seq": "6", "ce:initials": "T.", "@_fa": "true", "@type": "auth", "ce:surname": "Saethang", "@auid": "35073059200", "ce:indexed-name": "Saethang T."}, {"ce:given-name": "D. Michael", "preferred-name": {"ce:given-name": "D. Michael", "ce:initials": "D.M.", "ce:surname": "Payne", "ce:indexed-name": "Payne D.M."}, "@seq": "8", "ce:initials": "D.M.", "@_fa": "true", "@type": "auth", "ce:surname": "Payne", "@auid": "7402805350", "ce:indexed-name": "Payne D.M."}, {"ce:given-name": "Trairak", "preferred-name": {"ce:given-name": "Trairak", "ce:initials": "T.", "ce:surname": "Pisitkun", "ce:indexed-name": "Pisitkun T."}, "@seq": "9", "ce:initials": "T.", "@date-locked": "2018-04-23T06:02:08.785", "@_fa": "true", "@type": "auth", "ce:surname": "Pisitkun", "@auid": "6507728111", "ce:indexed-name": "Pisitkun T."}]}, {"affiliation": {"country": "Italy", "address-part": "Via Mangiagalli 25", "postal-code": "20133", "@afid": "60030318", "@country": "ita", "city": "Milan", "organization": [{"$": "Department of Pharmaceutical Sciences"}, {"$": "Universit\u00e0 degli Studi di Milano"}], "affiliation-id": {"@afid": "60030318", "@dptid": "108405016"}, "@dptid": "108405016"}, "author": [{"ce:given-name": "Luca", "preferred-name": {"ce:given-name": "Luca", "ce:initials": "L.", "ce:surname": "Cannizzaro", "ce:indexed-name": "Cannizzaro L."}, "@seq": "1", "ce:initials": "L.", "@_fa": "true", "@type": "auth", "ce:surname": "Cannizzaro", "@auid": "56809020400", "ce:indexed-name": "Cannizzaro L."}, {"ce:given-name": "Alessandra", "preferred-name": {"ce:given-name": "Alessandra", "ce:initials": "A.", "ce:surname": "Altomare", "ce:indexed-name": "Altomare A."}, "@seq": "4", "ce:initials": "A.", "@_fa": "true", "@type": "auth", "ce:surname": "Altomare", "@auid": "55587251500", "ce:indexed-name": "Altomare A."}, {"ce:given-name": "Cristina", "preferred-name": {"ce:given-name": "Cristina", "ce:initials": "C.", "ce:surname": "Marinello", "ce:indexed-name": "Marinello C."}, "@seq": "5", "ce:initials": "C.", "@_fa": "true", "@type": "auth", "ce:surname": "Marinello", "@auid": "7006556911", "ce:indexed-name": "Marinello C."}, {"ce:given-name": "Marina", "preferred-name": {"ce:given-name": "Marina", "ce:initials": "M.", "ce:surname": "Carini", "ce:indexed-name": "Carini M."}, "@seq": "7", "ce:initials": "M.", "@date-locked": "2017-05-12T11:34:59.761", "@_fa": "true", "@type": "auth", "ce:surname": "Carini", "@auid": "56271103700", "ce:indexed-name": "Carini M."}, {"ce:given-name": "Giancarlo", "preferred-name": {"ce:given-name": "Giancarlo", "ce:initials": "G.", "ce:surname": "Aldini", "ce:indexed-name": "Aldini G."}, "@seq": "10", "ce:initials": "G.", "@_fa": "true", "@type": "auth", "ce:surname": "Aldini", "@auid": "7003627860", "ce:indexed-name": "Aldini G."}]}, {"affiliation": {"country": "Italy", "address-part": "Via Vanvitelli 32", "postal-code": "20129", "@afid": "60030318", "@country": "ita", "city": "Milan", "organization": [{"$": "Department of Medical Biotechnology and Translational Medicine"}, {"$": "Universit\u00e0 degli Studi di Milano"}], "affiliation-id": {"@afid": "60030318", "@dptid": "113423956"}, "@dptid": "113423956"}, "author": [{"ce:given-name": "Giuseppe", "preferred-name": {"ce:given-name": "Giuseppe", "ce:initials": "G.", "ce:surname": "Rossoni", "ce:indexed-name": "Rossoni G."}, "@seq": "2", "ce:initials": "G.", "@_fa": "true", "@type": "auth", "ce:surname": "Rossoni", "@auid": "7006372950", "ce:indexed-name": "Rossoni G."}]}, {"affiliation": {"country": "Italy", "address-part": "Via di Rudin\u00ec 8", "postal-code": "20142", "@afid": "114289076", "@country": "ita", "city": "Milan", "organization": [{"$": "Pathological Anatomy Unit (U.O.C. Anatomia Patologica)"}, {"$": "ASST Santi Paolo e Carlo"}], "affiliation-id": {"@afid": "114289076"}}, "author": [{"ce:given-name": "Federica", "preferred-name": {"ce:given-name": "Federica", "ce:initials": "F.", "ce:surname": "Savi", "ce:indexed-name": "Savi F."}, "@seq": "3", "ce:initials": "F.", "@_fa": "true", "@type": "auth", "ce:surname": "Savi", "@auid": "11339836500", "ce:indexed-name": "Savi F."}]}, {"affiliation": {"country": "Thailand", "postal-code": "10330", "@afid": "60002620", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Center of Excellence in Immunology and Immune-mediated Diseases"}, {"$": "Department of Microbiology"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}], "affiliation-id": [{"@afid": "60002620", "@dptid": "103183424"}, {"@afid": "60028190"}], "@dptid": "103183424"}, "author": [{"ce:given-name": "Asada", "preferred-name": {"ce:given-name": "Asada", "ce:initials": "A.", "ce:surname": "Leelahavanichkul", "ce:indexed-name": "Leelahavanichkul A."}, "@seq": "11", "ce:initials": "A.", "@_fa": "true", "@type": "auth", "ce:surname": "Leelahavanichkul", "@auid": "24587653600", "ce:indexed-name": "Leelahavanichkul A."}]}], "citation-title": "Regulatory landscape of AGE-RAGE-oxidative stress axis and its modulation by PPAR\u03b3 activation in high fructose diet-induced metabolic syndrome", "abstracts": "\u00a9 2017 The Author(s).Background: The AGE-RAGE-oxidative stress (AROS) axis is involved in the onset and progression of metabolic syndrome induced by a high-fructose diet (HFD). PPAR\u03b3 activation is known to modulate metabolic syndrome; however a systems-level investigation looking at the protective effects of PPAR\u03b3 activation as related to the AROS axis has not been performed. The aim of this work is to simultaneously characterize multiple molecular parameters within the AROS axis, using samples taken from different body fluids and tissues of a rat model of HFD-induced metabolic syndrome, in the presence or absence of a PPAR\u03b3 agonist, Rosiglitazone (RGZ). Methods: Rats were fed with 60% HFD for the first half of the treatment duration (21 days) then continued with either HFD alone or HFD plus RGZ for the second half. Results: Rats receiving HFD alone showed metabolic syndrome manifestations including hypertension, dyslipidemia, increased glucose levels and insulin resistance, as well as abnormal kidney and inflammatory parameters. Systolic blood pressure, plasma triglyceride and glucose levels, plasma creatinine, and albuminuria were significantly improved in the presence of RGZ. The following molecular parameters of the AROS axis were significantly upregulated in our rat model: carboxymethyl lysine (CML) in urine and liver; carboxyethyl lysine (CEL) in urine; advanced glycation end products (AGEs) in plasma; receptor for advanced glycation end products (RAGE) in liver and kidney; advanced oxidation protein products (AOPP) in plasma; and 4-hydroxynonenal (HNE) in plasma, liver, and kidney. Conversely, with RGZ administration, the upregulation of AOPP and AGEs in plasma, CML and CEL in urine, RAGE in liver as well as HNE in plasma and liver was significantly counteracted/prevented. Conclusions: Our data demonstrate (i) the systems-level regulatory landscape of HFD-induced metabolic syndrome involving multiple molecular parameters, including HNE, AGEs and their receptor RAGE, and (ii) attenuation of metabolic syndrome by PPAR\u03b3 modulation.", "correspondence": {"affiliation": {"country": "Italy", "address-part": "Via Mangiagalli 25", "postal-code": "20133", "@country": "ita", "city": "Milan", "organization": [{"$": "Department of Pharmaceutical Sciences"}, {"$": "Universit\u00e0 degli Studi di Milano"}]}, "person": {"ce:initials": "G.", "ce:surname": "Aldini", "ce:indexed-name": "Aldini G."}}, "citation-info": {"author-keywords": {"author-keyword": [{"$": "AGE-RAGE-oxidative stress axis", "@xml:lang": "eng"}, {"$": "Fructose", "@xml:lang": "eng"}, {"$": "HNE", "@xml:lang": "eng"}, {"$": "Metabolic syndrome", "@xml:lang": "eng"}, {"$": "PPAR\u03b3", "@xml:lang": "eng"}, {"$": "Rosiglitazone", "@xml:lang": "eng"}]}, "citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"sourcetitle-abbrev": "Nutr. Metab.", "website": {"ce:e-address": {"$": "http://www.nutritionandmetabolism.com/home/", "@type": "email"}}, "@country": "gbr", "translated-sourcetitle": {"$": "Nutrition and Metabolism", "@xml:lang": "eng"}, "issn": {"$": "17437075", "@type": "electronic"}, "volisspag": {"voliss": {"@volume": "14", "@issue": "1"}, "pagerange": {"@first": "1", "@last": "13"}}, "@type": "j", "publicationyear": {"@first": "2017"}, "publisher": {"publishername": "BioMed Central Ltd.", "ce:e-address": {"$": "info@biomedcentral.com", "@type": "email"}}, "sourcetitle": "Nutrition and Metabolism", "@srcid": "15300154824", "publicationdate": {"month": "01", "year": "2017", "date-text": {"@xfab-added": "true", "$": "13 January 2017"}, "day": "13"}}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "EMCLASS", "classification": [{"classification-code": "29", "classification-description": "Clinical and Experimental Biochemistry"}, {"classification-code": "3", "classification-description": "Endocrinology"}, {"classification-code": "37", "classification-description": "Drug Literature Index"}]}, {"@type": "ASJC", "classification": [{"$": "2701"}, {"$": "2712"}, {"$": "2916"}]}, {"@type": "SUBJABBR", "classification": [{"$": "MEDI"}, {"$": "NURS"}]}]}, "chemicalgroup": {"chemicals": {"@source": "esbd", "chemical": [{"cas-registry-number": [{"$": "29343-52-0"}, {"$": "75899-68-2"}], "chemical-name": "4 hydroxynonenal"}, {"cas-registry-number": [{"$": "198785-73-8"}, {"$": "247590-69-8"}], "chemical-name": "advanced glycation end product receptor"}, {"cas-registry-number": [{"$": "9000-86-6"}, {"$": "9014-30-6"}], "enzyme-commission-number": "EC 2.6.1.2", "chemical-name": "alanine aminotransferase"}, {"cas-registry-number": "9000-97-9", "enzyme-commission-number": "EC 2.6.1.1", "chemical-name": "aspartate aminotransferase"}, {"cas-registry-number": [{"$": "19230-81-0"}, {"$": "60-27-5"}], "chemical-name": "creatinine"}, {"cas-registry-number": [{"$": "122320-73-4"}, {"$": "155141-29-0"}], "chemical-name": "rosiglitazone"}]}}}}, "item-info": {"copyright": {"$": "Copyright 2017 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "dbcollection": [{"$": "EMBASE"}, {"$": "EMBIO"}, {"$": "NURSNG"}, {"$": "REAXYSCAR"}, {"$": "RMC"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}], "history": {"date-created": {"@day": "20", "@timestamp": "BST 09:22:31", "@year": "2017", "@month": "02"}}, "itemidlist": {"itemid": [{"$": "614153002", "@idtype": "PUI"}, {"$": "660265704", "@idtype": "CAR-ID"}, {"$": "20170068924", "@idtype": "EMBASE"}, {"$": "2016843199", "@idtype": "EMBIO"}, {"$": "2017032177", "@idtype": "NURSNG"}, {"$": "20170165627", "@idtype": "REAXYSCAR"}, {"$": "2017027409", "@idtype": "RMC"}, {"$": "85010297712", "@idtype": "SCP"}, {"$": "85010297712", "@idtype": "SGR"}], "ce:doi": "10.1186/s12986-016-0149-z"}}, "tail": {"bibliography": {"@refcount": "51", "reference": [{"ref-fulltext": "Lustig RH, Schmidt LA, Brindis CD. Public health: the toxic truth about sugar. Nature. 2012;482:27-9.", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Public health: the toxic truth about sugar"}, "refd-itemidlist": {"itemid": {"$": "84856410314", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "482"}, "pagerange": {"@first": "27", "@last": "29"}}, "ref-text": "22297952", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.H.", "@_fa": "true", "ce:surname": "Lustig", "ce:indexed-name": "Lustig R.H."}, {"@seq": "2", "ce:initials": "L.A.", "@_fa": "true", "ce:surname": "Schmidt", "ce:indexed-name": "Schmidt L.A."}, {"@seq": "3", "ce:initials": "C.D.", "@_fa": "true", "ce:surname": "Brindis", "ce:indexed-name": "Brindis C.D."}]}, "ref-sourcetitle": "Nature"}}, {"ref-fulltext": "Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith Jr SC, International Diabetes Federation Task Force on E, Prevention, Hational Heart L, Blood I, American Heart A, World Heart F, International Atherosclerosis S, International Association for the Study of O. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120:1640-5.", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity"}, "refd-itemidlist": {"itemid": {"$": "70350245011", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "120"}, "pagerange": {"@first": "1640", "@last": "1645"}}, "ref-text": "International Diabetes Federation Task Force on E, Prevention Hational Heart L Blood I American Heart A World Heart F International Atherosclerosis S International Association for the Study of O 19805654", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.G.", "@_fa": "true", "ce:surname": "Alberti", "ce:indexed-name": "Alberti K.G."}, {"@seq": "2", "ce:initials": "R.H.", "@_fa": "true", "ce:surname": "Eckel", "ce:indexed-name": "Eckel R.H."}, {"@seq": "3", "ce:initials": "S.M.", "@_fa": "true", "ce:surname": "Grundy", "ce:indexed-name": "Grundy S.M."}, {"@seq": "4", "ce:initials": "P.Z.", "@_fa": "true", "ce:surname": "Zimmet", "ce:indexed-name": "Zimmet P.Z."}, {"@seq": "5", "ce:initials": "J.I.", "@_fa": "true", "ce:surname": "Cleeman", "ce:indexed-name": "Cleeman J.I."}, {"@seq": "6", "ce:initials": "K.A.", "@_fa": "true", "ce:surname": "Donato", "ce:indexed-name": "Donato K.A."}, {"@seq": "7", "ce:initials": "J.C.", "@_fa": "true", "ce:surname": "Fruchart", "ce:indexed-name": "Fruchart J.C."}, {"@seq": "8", "ce:initials": "W.P.", "@_fa": "true", "ce:surname": "James", "ce:indexed-name": "James W.P."}, {"@seq": "9", "ce:initials": "C.M.", "@_fa": "true", "ce:surname": "Loria", "ce:indexed-name": "Loria C.M."}, {"@seq": "10", "ce:initials": "S.C.", "@_fa": "true", "ce:surname": "Smith", "ce:suffix": "Jr.", "ce:indexed-name": "Smith S.C."}]}, "ref-sourcetitle": "Circulation"}}, {"ref-fulltext": "Hanson RL, Imperatore G, Bennett PH, Knowler WC. Components of the \u201cmetabolic syndrome\u201d and incidence of type two diabetes. Diabetes. 2002;51:3120-7.", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-title": {"ref-titletext": "Components of the \u201cmetabolic syndrome\u201d and incidence of type two diabetes"}, "refd-itemidlist": {"itemid": {"$": "0036787485", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "51"}, "pagerange": {"@first": "3120", "@last": "3127"}}, "ref-text": "12351457", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.L.", "@_fa": "true", "ce:surname": "Hanson", "ce:indexed-name": "Hanson R.L."}, {"@seq": "2", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Imperatore", "ce:indexed-name": "Imperatore G."}, {"@seq": "3", "ce:initials": "P.H.", "@_fa": "true", "ce:surname": "Bennett", "ce:indexed-name": "Bennett P.H."}, {"@seq": "4", "ce:initials": "W.C.", "@_fa": "true", "ce:surname": "Knowler", "ce:indexed-name": "Knowler W.C."}]}, "ref-sourcetitle": "Diabetes"}}, {"ref-fulltext": "Abdulla MH, Sattar MA, Johns EJ. The relation between fructose-induced metabolic syndrome and altered renal haemodynamic and excretory function in the Rat. Int J Nephrol. 2011;2011:934659.", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "The relation between fructose-induced metabolic syndrome and altered renal haemodynamic and excretory function in the Rat"}, "refd-itemidlist": {"itemid": {"$": "84864232454", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "2011"}, "pagerange": {"@first": "934659"}}, "ref-text": "21785727 3139200", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.H.", "@_fa": "true", "ce:surname": "Abdulla", "ce:indexed-name": "Abdulla M.H."}, {"@seq": "2", "ce:initials": "M.A.", "@_fa": "true", "ce:surname": "Sattar", "ce:indexed-name": "Sattar M.A."}, {"@seq": "3", "ce:initials": "E.J.", "@_fa": "true", "ce:surname": "Johns", "ce:indexed-name": "Johns E.J."}]}, "ref-sourcetitle": "Int J Nephrol"}}, {"ref-fulltext": "Maessen DEM, Stehouwer CDA, Schalkwijk CG. The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases. Clin Sci. 2015;128:839-61.", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases"}, "refd-itemidlist": {"itemid": {"$": "84929942019", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "128"}, "pagerange": {"@first": "839", "@last": "861"}}, "ref-text": "25818485", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.E.M.", "@_fa": "true", "ce:surname": "Maessen", "ce:indexed-name": "Maessen D.E.M."}, {"@seq": "2", "ce:initials": "C.D.A.", "@_fa": "true", "ce:surname": "Stehouwer", "ce:indexed-name": "Stehouwer C.D.A."}, {"@seq": "3", "ce:initials": "C.G.", "@_fa": "true", "ce:surname": "Schalkwijk", "ce:indexed-name": "Schalkwijk C.G."}]}, "ref-sourcetitle": "Clin Sci"}}, {"ref-fulltext": "Schleicher ED, Wagner E, Nerlich AG. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest. 1997;99:457-68.", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "1997"}, "ref-title": {"ref-titletext": "Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging"}, "refd-itemidlist": {"itemid": {"$": "0030763201", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "99"}, "pagerange": {"@first": "457", "@last": "468"}}, "ref-text": "9022079 507819", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.D.", "@_fa": "true", "ce:surname": "Schleicher", "ce:indexed-name": "Schleicher E.D."}, {"@seq": "2", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Wagner", "ce:indexed-name": "Wagner E."}, {"@seq": "3", "ce:initials": "A.G.", "@_fa": "true", "ce:surname": "Nerlich", "ce:indexed-name": "Nerlich A.G."}]}, "ref-sourcetitle": "J Clin Invest"}}, {"ref-fulltext": "Ahmed MU, Brinkmann Frye E, Degenhardt TP, Thorpe SR, Baynes JW. N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J. 1997;324(Pt 2):565-70.", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "1997"}, "ref-title": {"ref-titletext": "N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins"}, "refd-itemidlist": {"itemid": {"$": "0030919275", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "324"}, "pagerange": {"@first": "565", "@last": "570"}}, "ref-text": "9182719 1218467", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.U.", "@_fa": "true", "ce:surname": "Ahmed", "ce:indexed-name": "Ahmed M.U."}, {"@seq": "2", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Brinkmann Frye", "ce:indexed-name": "Brinkmann Frye E."}, {"@seq": "3", "ce:initials": "T.P.", "@_fa": "true", "ce:surname": "Degenhardt", "ce:indexed-name": "Degenhardt T.P."}, {"@seq": "4", "ce:initials": "S.R.", "@_fa": "true", "ce:surname": "Thorpe", "ce:indexed-name": "Thorpe S.R."}, {"@seq": "5", "ce:initials": "J.W.", "@_fa": "true", "ce:surname": "Baynes", "ce:indexed-name": "Baynes J.W."}]}, "ref-sourcetitle": "Biochem J"}}, {"ref-fulltext": "Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, Stern DM, Nawroth PP. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl). 2005;83:876-86.", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "Understanding RAGE, the receptor for advanced glycation end products"}, "refd-itemidlist": {"itemid": {"$": "27744453362", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "83"}, "pagerange": {"@first": "876", "@last": "886"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Bierhaus", "ce:indexed-name": "Bierhaus A."}, {"@seq": "2", "ce:initials": "P.M.", "@_fa": "true", "ce:surname": "Humpert", "ce:indexed-name": "Humpert P.M."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Morcos", "ce:indexed-name": "Morcos M."}, {"@seq": "4", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Wendt", "ce:indexed-name": "Wendt T."}, {"@seq": "5", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Chavakis", "ce:indexed-name": "Chavakis T."}, {"@seq": "6", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Arnold", "ce:indexed-name": "Arnold B."}, {"@seq": "7", "ce:initials": "D.M.", "@_fa": "true", "ce:surname": "Stern", "ce:indexed-name": "Stern D.M."}, {"@seq": "8", "ce:initials": "P.P.", "@_fa": "true", "ce:surname": "Nawroth", "ce:indexed-name": "Nawroth P.P."}]}, "ref-sourcetitle": "J Mol Med (Berl)"}}, {"ref-fulltext": "Kaneto H, Fujii J, Myint T, Miyazawa N, Islam KN, Kawasaki Y, Suzuki K, Nakamura M, Tatsumi H, Yamasaki Y, Taniguchi N. Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction. Biochem J. 1996;320(Pt 3):855-63.", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "1996"}, "ref-title": {"ref-titletext": "Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction"}, "refd-itemidlist": {"itemid": {"$": "0030456403", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "320"}, "pagerange": {"@first": "855", "@last": "863"}}, "ref-text": "9003372 1218007", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Kaneto", "ce:indexed-name": "Kaneto H."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Fujii", "ce:indexed-name": "Fujii J."}, {"@seq": "3", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Myint", "ce:indexed-name": "Myint T."}, {"@seq": "4", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Miyazawa", "ce:indexed-name": "Miyazawa N."}, {"@seq": "5", "ce:initials": "K.N.", "@_fa": "true", "ce:surname": "Islam", "ce:indexed-name": "Islam K.N."}, {"@seq": "6", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Kawasaki", "ce:indexed-name": "Kawasaki Y."}, {"@seq": "7", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Suzuki", "ce:indexed-name": "Suzuki K."}, {"@seq": "8", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Nakamura", "ce:indexed-name": "Nakamura M."}, {"@seq": "9", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Tatsumi", "ce:indexed-name": "Tatsumi H."}, {"@seq": "10", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Yamasaki", "ce:indexed-name": "Yamasaki Y."}, {"@seq": "11", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Taniguchi", "ce:indexed-name": "Taniguchi N."}]}, "ref-sourcetitle": "Biochem J"}}, {"ref-fulltext": "Faure P, Rossini E, Lafond JL, Richard MJ, Favier A, Halimi S. Vitamin E improves the free radical defense system potential and insulin sensitivity of rats fed high fructose diets. J Nutr. 1997;127:103-7.", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "1997"}, "ref-title": {"ref-titletext": "Vitamin E improves the free radical defense system potential and insulin sensitivity of rats fed high fructose diets"}, "refd-itemidlist": {"itemid": {"$": "0031036134", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "127"}, "pagerange": {"@first": "103", "@last": "107"}}, "ref-text": "9040552", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Faure", "ce:indexed-name": "Faure P."}, {"@seq": "2", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Rossini", "ce:indexed-name": "Rossini E."}, {"@seq": "3", "ce:initials": "J.L.", "@_fa": "true", "ce:surname": "Lafond", "ce:indexed-name": "Lafond J.L."}, {"@seq": "4", "ce:initials": "M.J.", "@_fa": "true", "ce:surname": "Richard", "ce:indexed-name": "Richard M.J."}, {"@seq": "5", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Favier", "ce:indexed-name": "Favier A."}, {"@seq": "6", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Halimi", "ce:indexed-name": "Halimi S."}]}, "ref-sourcetitle": "J Nutr"}}, {"ref-fulltext": "Rajasekar P, Viswanathan P, Anuradha CV. Renoprotective action of L-carnitine in fructose-induced metabolic syndrome. Diabetes Obes Metab. 2008;10:171-80.", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Renoprotective action of L-carnitine in fructose-induced metabolic syndrome"}, "refd-itemidlist": {"itemid": {"$": "38049113001", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "10"}, "pagerange": {"@first": "171", "@last": "180"}}, "ref-text": "18093214", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Rajasekar", "ce:indexed-name": "Rajasekar P."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Viswanathan", "ce:indexed-name": "Viswanathan P."}, {"@seq": "3", "ce:initials": "C.V.", "@_fa": "true", "ce:surname": "Anuradha", "ce:indexed-name": "Anuradha C.V."}]}, "ref-sourcetitle": "Diabetes Obes Metab"}}, {"ref-fulltext": "Iacobini C, Menini S, Ricci C, Scipioni A, Sansoni V, Mazzitelli G, Cordone S, Pesce C, Pugliese F, Pricci F, Pugliese G. Advanced lipoxidation end-products mediate lipid-induced glomerular injury: role of receptor-mediated mechanisms. J Pathol. 2009;218:360-9.", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Advanced lipoxidation end-products mediate lipid-induced glomerular injury: role of receptor-mediated mechanisms"}, "refd-itemidlist": {"itemid": {"$": "67650046377", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "218"}, "pagerange": {"@first": "360", "@last": "369"}}, "ref-text": "19334049", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Iacobini", "ce:indexed-name": "Iacobini C."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Menini", "ce:indexed-name": "Menini S."}, {"@seq": "3", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Ricci", "ce:indexed-name": "Ricci C."}, {"@seq": "4", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Scipioni", "ce:indexed-name": "Scipioni A."}, {"@seq": "5", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Sansoni", "ce:indexed-name": "Sansoni V."}, {"@seq": "6", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Mazzitelli", "ce:indexed-name": "Mazzitelli G."}, {"@seq": "7", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Cordone", "ce:indexed-name": "Cordone S."}, {"@seq": "8", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Pesce", "ce:indexed-name": "Pesce C."}, {"@seq": "9", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Pugliese", "ce:indexed-name": "Pugliese F."}, {"@seq": "10", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Pricci", "ce:indexed-name": "Pricci F."}, {"@seq": "11", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Pugliese", "ce:indexed-name": "Pugliese G."}]}, "ref-sourcetitle": "J Pathol"}}, {"ref-fulltext": "Kannappan S, Palanisamy N, Anuradha CV. Suppression of hepatic oxidative events and regulation of eNOS expression in the liver by naringenin in fructose-administered rats. Eur J Pharmacol. 2010;645:177-84.", "@id": "13", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Suppression of hepatic oxidative events and regulation of eNOS expression in the liver by naringenin in fructose-administered rats"}, "refd-itemidlist": {"itemid": {"$": "77956184900", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "645"}, "pagerange": {"@first": "177", "@last": "184"}}, "ref-text": "20655900", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Kannappan", "ce:indexed-name": "Kannappan S."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Palanisamy", "ce:indexed-name": "Palanisamy N."}, {"@seq": "3", "ce:initials": "C.V.", "@_fa": "true", "ce:surname": "Anuradha", "ce:indexed-name": "Anuradha C.V."}]}, "ref-sourcetitle": "Eur J Pharmacol"}}, {"ref-fulltext": "Dixit VA, Bharatam PV. SAR and computer-aided drug design approaches in the discovery of peroxisome proliferator-activated receptor \u03b3 activators: a perspective. J Computational Med. 2013;2013:38.", "@id": "14", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "SAR and computer-aided drug design approaches in the discovery of peroxisome proliferator-activated receptor \u03b3 activators: a perspective"}, "refd-itemidlist": {"itemid": {"$": "84939514709", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "2013"}, "pagerange": {"@first": "38"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "V.A.", "@_fa": "true", "ce:surname": "Dixit", "ce:indexed-name": "Dixit V.A."}, {"@seq": "2", "ce:initials": "P.V.", "@_fa": "true", "ce:surname": "Bharatam", "ce:indexed-name": "Bharatam P.V."}]}, "ref-sourcetitle": "J Computational Med"}}, {"ref-fulltext": "Saha S, Chan DS, Lee CY, Wong W, New LS, Chui WK, Yap CW, Chan EC, Ho HK. Pyrrolidinediones reduce the toxicity of thiazolidinediones and modify their anti-diabetic and anti-cancer properties. Eur J Pharmacol. 2012;697:13-23.", "@id": "15", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Pyrrolidinediones reduce the toxicity of thiazolidinediones and modify their anti-diabetic and anti-cancer properties"}, "refd-itemidlist": {"itemid": {"$": "84869490816", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "697"}, "pagerange": {"@first": "13", "@last": "23"}}, "ref-text": "23041271", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Saha", "ce:indexed-name": "Saha S."}, {"@seq": "2", "ce:initials": "D.S.", "@_fa": "true", "ce:surname": "Chan", "ce:indexed-name": "Chan D.S."}, {"@seq": "3", "ce:initials": "C.Y.", "@_fa": "true", "ce:surname": "Lee", "ce:indexed-name": "Lee C.Y."}, {"@seq": "4", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Wong", "ce:indexed-name": "Wong W."}, {"@seq": "5", "ce:initials": "L.S.", "@_fa": "true", "ce:surname": "New", "ce:indexed-name": "New L.S."}, {"@seq": "6", "ce:initials": "W.K.", "@_fa": "true", "ce:surname": "Chui", "ce:indexed-name": "Chui W.K."}, {"@seq": "7", "ce:initials": "C.W.", "@_fa": "true", "ce:surname": "Yap", "ce:indexed-name": "Yap C.W."}, {"@seq": "8", "ce:initials": "E.C.", "@_fa": "true", "ce:surname": "Chan", "ce:indexed-name": "Chan E.C."}, {"@seq": "9", "ce:initials": "H.K.", "@_fa": "true", "ce:surname": "Ho", "ce:indexed-name": "Ho H.K."}]}, "ref-sourcetitle": "Eur J Pharmacol"}}, {"ref-fulltext": "Geurin MD, St Anna L. Thiazolidinedione therapy for managing metabolic syndrome. Am Fam Physician. 2010;82:1553-4.", "@id": "16", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Thiazolidinedione therapy for managing metabolic syndrome"}, "refd-itemidlist": {"itemid": {"$": "79952276940", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "82"}, "pagerange": {"@first": "1553", "@last": "1554"}}, "ref-text": "21166377", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.D.", "@_fa": "true", "ce:surname": "Geurin", "ce:indexed-name": "Geurin M.D."}, {"@seq": "2", "ce:initials": "L.", "@_fa": "true", "ce:surname": "St Anna", "ce:indexed-name": "St Anna L."}]}, "ref-sourcetitle": "Am Fam Physician"}}, {"ref-fulltext": "Davaa E, Kang BS, Han JH, Lee SE, Ng CL, Myung CS, Park JS. Combined delivery of the adiponectin gene and rosiglitazone using cationic lipid emulsions. Int J Pharm. 2015;483:124-30.", "@id": "17", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Combined delivery of the adiponectin gene and rosiglitazone using cationic lipid emulsions"}, "refd-itemidlist": {"itemid": {"$": "84923116676", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "483"}, "pagerange": {"@first": "124", "@last": "130"}}, "ref-text": "25681724", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Davaa", "ce:indexed-name": "Davaa E."}, {"@seq": "2", "ce:initials": "B.S.", "@_fa": "true", "ce:surname": "Kang", "ce:indexed-name": "Kang B.S."}, {"@seq": "3", "ce:initials": "J.H.", "@_fa": "true", "ce:surname": "Han", "ce:indexed-name": "Han J.H."}, {"@seq": "4", "ce:initials": "S.E.", "@_fa": "true", "ce:surname": "Lee", "ce:indexed-name": "Lee S.E."}, {"@seq": "5", "ce:initials": "C.L.", "@_fa": "true", "ce:surname": "Ng", "ce:indexed-name": "Ng C.L."}, {"@seq": "6", "ce:initials": "C.S.", "@_fa": "true", "ce:surname": "Myung", "ce:indexed-name": "Myung C.S."}, {"@seq": "7", "ce:initials": "J.S.", "@_fa": "true", "ce:surname": "Park", "ce:indexed-name": "Park J.S."}]}, "ref-sourcetitle": "Int J Pharm"}}, {"ref-fulltext": "Yki-Jarvinen H. Thiazolidinediones. N Engl J Med. 2004;351:1106-18.", "@id": "18", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Thiazolidinediones"}, "refd-itemidlist": {"itemid": {"$": "19244365650", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "351"}, "pagerange": {"@first": "1106", "@last": "1118"}}, "ref-text": "15356308", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Yki-Jarvinen", "ce:indexed-name": "Yki-Jarvinen H."}]}, "ref-sourcetitle": "N Engl J Med"}}, {"ref-fulltext": "Vasudevan AR, Balasubramanyam A. Thiazolidinediones: a review of their mechanisms of insulin sensitization, therapeutic potential, clinical efficacy, and tolerability. Diabetes Technol Ther. 2004;6:850-63.", "@id": "19", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Thiazolidinediones: a review of their mechanisms of insulin sensitization, therapeutic potential, clinical efficacy, and tolerability"}, "refd-itemidlist": {"itemid": {"$": "12344316682", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "6"}, "pagerange": {"@first": "850", "@last": "863"}}, "ref-text": "15684639", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.R.", "@_fa": "true", "ce:surname": "Vasudevan", "ce:indexed-name": "Vasudevan A.R."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Balasubramanyam", "ce:indexed-name": "Balasubramanyam A."}]}, "ref-sourcetitle": "Diabetes Technol Ther"}}, {"ref-fulltext": "Hsu WH, Lee BH, Hsu YW, Pan TM. Peroxisome proliferator-activated receptor-gamma activators monascin and rosiglitazone attenuate carboxymethyllysine-induced fibrosis in hepatic stellate cells through regulating the oxidative stress pathway but independent of the receptor for advanced glycation end products signaling. J Agric Food Chem. 2013;61:6873-9.", "@id": "20", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Peroxisome proliferator-activated receptor-gamma activators monascin and rosiglitazone attenuate carboxymethyllysine-induced fibrosis in hepatic stellate cells through regulating the oxidative stress pathway but independent of the receptor for advanced glycation end products signaling"}, "refd-itemidlist": {"itemid": {"$": "84880339801", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "61"}, "pagerange": {"@first": "6873", "@last": "6879"}}, "ref-text": "23796251", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "W.H.", "@_fa": "true", "ce:surname": "Hsu", "ce:indexed-name": "Hsu W.H."}, {"@seq": "2", "ce:initials": "B.H.", "@_fa": "true", "ce:surname": "Lee", "ce:indexed-name": "Lee B.H."}, {"@seq": "3", "ce:initials": "Y.W.", "@_fa": "true", "ce:surname": "Hsu", "ce:indexed-name": "Hsu Y.W."}, {"@seq": "4", "ce:initials": "T.M.", "@_fa": "true", "ce:surname": "Pan", "ce:indexed-name": "Pan T.M."}]}, "ref-sourcetitle": "J Agric Food Chem"}}, {"ref-fulltext": "Morcos M, Schlotterer A, Sayed AA, Kukudov G, Oikomonou D, Ibrahim Y, Pfisterer F, Schneider J, Bozorgmehr F, Rudofsky G, Schwenger V, Kientsch-Engels R, Hamann A, Zeier M, Dugi K, Yard B, Humpert PM, van der Woude F, Nawroth PP, Bierhaus A. Rosiglitazone reduces angiotensin II and advanced glycation end product-dependent sustained nuclear factor-kappaB activation in cultured human proximal tubular epithelial cells. Horm Metab Res. 2008;40:752-9.", "@id": "21", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Rosiglitazone reduces angiotensin II and advanced glycation end product-dependent sustained nuclear factor-kappaB activation in cultured human proximal tubular epithelial cells"}, "refd-itemidlist": {"itemid": {"$": "59849100342", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "40"}, "pagerange": {"@first": "752", "@last": "759"}}, "ref-text": "18711692", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Morcos", "ce:indexed-name": "Morcos M."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Schlotterer", "ce:indexed-name": "Schlotterer A."}, {"@seq": "3", "ce:initials": "A.A.", "@_fa": "true", "ce:surname": "Sayed", "ce:indexed-name": "Sayed A.A."}, {"@seq": "4", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Kukudov", "ce:indexed-name": "Kukudov G."}, {"@seq": "5", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Oikomonou", "ce:indexed-name": "Oikomonou D."}, {"@seq": "6", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Ibrahim", "ce:indexed-name": "Ibrahim Y."}, {"@seq": "7", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Pfisterer", "ce:indexed-name": "Pfisterer F."}, {"@seq": "8", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Schneider", "ce:indexed-name": "Schneider J."}, {"@seq": "9", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Bozorgmehr", "ce:indexed-name": "Bozorgmehr F."}, {"@seq": "10", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Rudofsky", "ce:indexed-name": "Rudofsky G."}, {"@seq": "11", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Schwenger", "ce:indexed-name": "Schwenger V."}, {"@seq": "12", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Kientsch-Engels", "ce:indexed-name": "Kientsch-Engels R."}, {"@seq": "13", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Hamann", "ce:indexed-name": "Hamann A."}, {"@seq": "14", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Zeier", "ce:indexed-name": "Zeier M."}, {"@seq": "15", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Dugi", "ce:indexed-name": "Dugi K."}, {"@seq": "16", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Yard", "ce:indexed-name": "Yard B."}, {"@seq": "17", "ce:initials": "P.M.", "@_fa": "true", "ce:surname": "Humpert", "ce:indexed-name": "Humpert P.M."}, {"@seq": "18", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Van der Woude", "ce:indexed-name": "Van der Woude F."}, {"@seq": "19", "ce:initials": "P.P.", "@_fa": "true", "ce:surname": "Nawroth", "ce:indexed-name": "Nawroth P.P."}, {"@seq": "20", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Bierhaus", "ce:indexed-name": "Bierhaus A."}]}, "ref-sourcetitle": "Horm Metab Res"}}, {"ref-fulltext": "Buss ZS, Medeiros YS, Fr\u00f6de TS. PPAR-gamma agonist rosiglitazone attenuates the inflammation caused by carrageenan in the mouse model of pleurisy. Inflammation. 2012;35:280-8.", "@id": "22", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "PPAR-gamma agonist rosiglitazone attenuates the inflammation caused by carrageenan in the mouse model of pleurisy"}, "refd-itemidlist": {"itemid": {"$": "84859428437", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "35"}, "pagerange": {"@first": "280", "@last": "288"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Z.S.", "@_fa": "true", "ce:surname": "Buss", "ce:indexed-name": "Buss Z.S."}, {"@seq": "2", "ce:initials": "Y.S.", "@_fa": "true", "ce:surname": "Medeiros", "ce:indexed-name": "Medeiros Y.S."}, {"@seq": "3", "ce:initials": "T.S.", "@_fa": "true", "ce:surname": "Fr\u00f6de", "ce:indexed-name": "Frode T.S."}]}, "ref-sourcetitle": "Inflammation"}}, {"ref-fulltext": "Wang L, Yu CJ, Liu W, Cheng LY, Zhang YN. Rosiglitazone protects neuroblastoma cells against advanced glycation end products-induced injury. Acta Pharmacol Sin. 2011;32:991-8.", "@id": "23", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Rosiglitazone protects neuroblastoma cells against advanced glycation end products-induced injury"}, "refd-itemidlist": {"itemid": {"$": "80051514413", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "32"}, "pagerange": {"@first": "991", "@last": "998"}}, "ref-text": "21765445 4002533", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Wang", "ce:indexed-name": "Wang L."}, {"@seq": "2", "ce:initials": "C.J.", "@_fa": "true", "ce:surname": "Yu", "ce:indexed-name": "Yu C.J."}, {"@seq": "3", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Liu", "ce:indexed-name": "Liu W."}, {"@seq": "4", "ce:initials": "L.Y.", "@_fa": "true", "ce:surname": "Cheng", "ce:indexed-name": "Cheng L.Y."}, {"@seq": "5", "ce:initials": "Y.N.", "@_fa": "true", "ce:surname": "Zhang", "ce:indexed-name": "Zhang Y.N."}]}, "ref-sourcetitle": "Acta Pharmacol Sin"}}, {"ref-fulltext": "Liang C, Ren Y, Tan H, He Z, Jiang Q, Wu J, Zhen Y, Fan M, Wu Z. Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products. Br J Pharmacol. 2009;158:1865-73.", "@id": "24", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products"}, "refd-itemidlist": {"itemid": {"$": "71649112618", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "158"}, "pagerange": {"@first": "1865", "@last": "1873"}}, "ref-text": "19917066 2807648", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Liang", "ce:indexed-name": "Liang C."}, {"@seq": "2", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Ren", "ce:indexed-name": "Ren Y."}, {"@seq": "3", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Tan", "ce:indexed-name": "Tan H."}, {"@seq": "4", "ce:initials": "Z.", "@_fa": "true", "ce:surname": "He", "ce:indexed-name": "He Z."}, {"@seq": "5", "ce:initials": "Q.", "@_fa": "true", "ce:surname": "Jiang", "ce:indexed-name": "Jiang Q."}, {"@seq": "6", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Wu", "ce:indexed-name": "Wu J."}, {"@seq": "7", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Zhen", "ce:indexed-name": "Zhen Y."}, {"@seq": "8", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Fan", "ce:indexed-name": "Fan M."}, {"@seq": "9", "ce:initials": "Z.", "@_fa": "true", "ce:surname": "Wu", "ce:indexed-name": "Wu Z."}]}, "ref-sourcetitle": "Br J Pharmacol"}}, {"ref-fulltext": "Wang SH, Sun ZL, Guo YJ, Yuan Y, Li L. PPARgamma-mediated advanced glycation end products regulation of neural stem cells. Mol Cell Endocrinol. 2009;307:176-84.", "@id": "25", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "PPARgamma-mediated advanced glycation end products regulation of neural stem cells"}, "refd-itemidlist": {"itemid": {"$": "67349088792", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "307"}, "pagerange": {"@first": "176", "@last": "184"}}, "ref-text": "19524138", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.H.", "@_fa": "true", "ce:surname": "Wang", "ce:indexed-name": "Wang S.H."}, {"@seq": "2", "ce:initials": "Z.L.", "@_fa": "true", "ce:surname": "Sun", "ce:indexed-name": "Sun Z.L."}, {"@seq": "3", "ce:initials": "Y.J.", "@_fa": "true", "ce:surname": "Guo", "ce:indexed-name": "Guo Y.J."}, {"@seq": "4", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Yuan", "ce:indexed-name": "Yuan Y."}, {"@seq": "5", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Li", "ce:indexed-name": "Li L."}]}, "ref-sourcetitle": "Mol Cell Endocrinol"}}, {"ref-fulltext": "Altabas V. Drug treatment of metabolic syndrome. Curr Clin Pharmacol. 2013;8:224-31.", "@id": "26", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Drug treatment of metabolic syndrome"}, "refd-itemidlist": {"itemid": {"$": "84882799486", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "8"}, "pagerange": {"@first": "224", "@last": "231"}}, "ref-text": "22950955", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Altabas", "ce:indexed-name": "Altabas V."}]}, "ref-sourcetitle": "Curr Clin Pharmacol"}}, {"ref-fulltext": "Karak M, Bal NC, Bal C, Sharon A. Targeting peroxisome proliferator-activated receptor gamma for generation of antidiabetic drug. Curr Diabetes Rev. 2013;9:275-85.", "@id": "27", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Targeting peroxisome proliferator-activated receptor gamma for generation of antidiabetic drug"}, "refd-itemidlist": {"itemid": {"$": "84892977814", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "9"}, "pagerange": {"@first": "275", "@last": "285"}}, "ref-text": "23746081", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Karak", "ce:indexed-name": "Karak M."}, {"@seq": "2", "ce:initials": "N.C.", "@_fa": "true", "ce:surname": "Bal", "ce:indexed-name": "Bal N.C."}, {"@seq": "3", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Bal", "ce:indexed-name": "Bal C."}, {"@seq": "4", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Sharon", "ce:indexed-name": "Sharon A."}]}, "ref-sourcetitle": "Curr Diabetes Rev"}}, {"ref-fulltext": "Chen KC, Chen CY. In silico identification of potent PPAR-gamma agonists from traditional Chinese medicine: a bioactivity prediction, virtual screening, and molecular dynamics study. Evid Based Complement Alternat Med. 2014;2014:192452.", "@id": "28", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "In silico identification of potent PPAR-gamma agonists from traditional Chinese medicine: a bioactivity prediction, virtual screening, and molecular dynamics study"}, "refd-itemidlist": {"itemid": {"$": "84902158832", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "2014"}, "pagerange": {"@first": "192452"}}, "ref-text": "24971147 4058246", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.C.", "@_fa": "true", "ce:surname": "Chen", "ce:indexed-name": "Chen K.C."}, {"@seq": "2", "ce:initials": "C.Y.", "@_fa": "true", "ce:surname": "Chen", "ce:indexed-name": "Chen C.Y."}]}, "ref-sourcetitle": "Evid Based Complement Alternat Med"}}, {"ref-fulltext": "Jia Z, Sun Y, Yang G, Zhang A, Huang S, Heiney KM, Zhang Y. New insights into the PPAR gamma agonists for the treatment of diabetic nephropathy. PPAR Res. 2014;2014:818530.", "@id": "29", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "New insights into the PPAR gamma agonists for the treatment of diabetic nephropathy"}, "refd-itemidlist": {"itemid": {"$": "84896825651", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "2014"}, "pagerange": {"@first": "818530"}}, "ref-text": "24624137 3927865", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Z.", "@_fa": "true", "ce:surname": "Jia", "ce:indexed-name": "Jia Z."}, {"@seq": "2", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Sun", "ce:indexed-name": "Sun Y."}, {"@seq": "3", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Yang", "ce:indexed-name": "Yang G."}, {"@seq": "4", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Zhang", "ce:indexed-name": "Zhang A."}, {"@seq": "5", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Huang", "ce:indexed-name": "Huang S."}, {"@seq": "6", "ce:initials": "K.M.", "@_fa": "true", "ce:surname": "Heiney", "ce:indexed-name": "Heiney K.M."}, {"@seq": "7", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Zhang", "ce:indexed-name": "Zhang Y."}]}, "ref-sourcetitle": "PPAR Res"}}, {"ref-fulltext": "Chang F, Jaber LA, Berlie HD, O\u2019Connell MB. Evolution of peroxisome proliferator-activated receptor agonists. Ann Pharmacother. 2007;41:973-83.", "@id": "30", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Evolution of peroxisome proliferator-activated receptor agonists"}, "refd-itemidlist": {"itemid": {"$": "34250213233", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "41"}, "pagerange": {"@first": "973", "@last": "983"}}, "ref-text": "17519293", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Chang", "ce:indexed-name": "Chang F."}, {"@seq": "2", "ce:initials": "L.A.", "@_fa": "true", "ce:surname": "Jaber", "ce:indexed-name": "Jaber L.A."}, {"@seq": "3", "ce:initials": "H.D.", "@_fa": "true", "ce:surname": "Berlie", "ce:indexed-name": "Berlie H.D."}, {"@seq": "4", "ce:initials": "M.B.", "@_fa": "true", "ce:surname": "O\u2019Connell", "ce:indexed-name": "O'Connell M.B."}]}, "ref-sourcetitle": "Ann Pharmacother"}}, {"ref-fulltext": "Aldini G, Orioli M, Rossoni G, Savi F, Braidotti P, Vistoli G, Yeum KJ, Negrisoli G, Carini M. The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in zucker obese rats. J Cell Mol Med. 2011;15:1339-54.", "@id": "31", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in zucker obese rats"}, "refd-itemidlist": {"itemid": {"$": "79957651591", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "15"}, "pagerange": {"@first": "1339", "@last": "1354"}}, "ref-text": "20518851", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Aldini", "ce:indexed-name": "Aldini G."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Orioli", "ce:indexed-name": "Orioli M."}, {"@seq": "3", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Rossoni", "ce:indexed-name": "Rossoni G."}, {"@seq": "4", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Savi", "ce:indexed-name": "Savi F."}, {"@seq": "5", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Braidotti", "ce:indexed-name": "Braidotti P."}, {"@seq": "6", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Vistoli", "ce:indexed-name": "Vistoli G."}, {"@seq": "7", "ce:initials": "K.J.", "@_fa": "true", "ce:surname": "Yeum", "ce:indexed-name": "Yeum K.J."}, {"@seq": "8", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Negrisoli", "ce:indexed-name": "Negrisoli G."}, {"@seq": "9", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Carini", "ce:indexed-name": "Carini M."}]}, "ref-sourcetitle": "J Cell Mol Med"}}, {"ref-fulltext": "RD B. Blood pressure measurement in rats. In: Handbook of hypertension. Amsterdam: Elsevier; 1994. p. 17.", "@id": "32", "ref-info": {"ref-publicationyear": {"@first": "1994"}, "ref-title": {"ref-titletext": "Blood pressure measurement in rats"}, "refd-itemidlist": {"itemid": {"$": "85010385750", "@idtype": "SGR"}}, "ref-volisspag": {"pagerange": {"@first": "17"}}, "ref-text": "Elsevier Amsterdam", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Rd", "ce:indexed-name": "Rd B."}]}, "ref-sourcetitle": "Handbook of hypertension"}}, {"ref-fulltext": "Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillere-Blandin C, Nguyen AT, Canteloup S, Dayer JM, Jungers P, Drueke T, Descamps-Latscha B. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol. 1998;161:2524-32.", "@id": "33", "ref-info": {"ref-publicationyear": {"@first": "1998"}, "ref-title": {"ref-titletext": "Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure"}, "refd-itemidlist": {"itemid": {"$": "18844471606", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "161"}, "pagerange": {"@first": "2524", "@last": "2532"}}, "ref-text": "9725252", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Witko-Sarsat", "ce:indexed-name": "Witko-Sarsat V."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Friedlander", "ce:indexed-name": "Friedlander M."}, {"@seq": "3", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Nguyen Khoa", "ce:indexed-name": "Nguyen Khoa T."}, {"@seq": "4", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Capeillere-Blandin", "ce:indexed-name": "Capeillere-Blandin C."}, {"@seq": "5", "ce:initials": "A.T.", "@_fa": "true", "ce:surname": "Nguyen", "ce:indexed-name": "Nguyen A.T."}, {"@seq": "6", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Canteloup", "ce:indexed-name": "Canteloup S."}, {"@seq": "7", "ce:initials": "J.M.", "@_fa": "true", "ce:surname": "Dayer", "ce:indexed-name": "Dayer J.M."}, {"@seq": "8", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Jungers", "ce:indexed-name": "Jungers P."}, {"@seq": "9", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Drueke", "ce:indexed-name": "Drueke T."}, {"@seq": "10", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Descamps-Latscha", "ce:indexed-name": "Descamps-Latscha B."}]}, "ref-sourcetitle": "J Immunol"}}, {"ref-fulltext": "Ackerman Z, Oron-Herman M, Grozovski M, Rosenthal T, Pappo O, Link G, Sela BA. Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction. Hypertension. 2005;45:1012-8.", "@id": "34", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction"}, "refd-itemidlist": {"itemid": {"$": "18244375243", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "45"}, "pagerange": {"@first": "1012", "@last": "1018"}}, "ref-text": "15824194", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Z.", "@_fa": "true", "ce:surname": "Ackerman", "ce:indexed-name": "Ackerman Z."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Oron-Herman", "ce:indexed-name": "Oron-Herman M."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Grozovski", "ce:indexed-name": "Grozovski M."}, {"@seq": "4", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Rosenthal", "ce:indexed-name": "Rosenthal T."}, {"@seq": "5", "ce:initials": "O.", "@_fa": "true", "ce:surname": "Pappo", "ce:indexed-name": "Pappo O."}, {"@seq": "6", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Link", "ce:indexed-name": "Link G."}, {"@seq": "7", "ce:initials": "B.A.", "@_fa": "true", "ce:surname": "Sela", "ce:indexed-name": "Sela B.A."}]}, "ref-sourcetitle": "Hypertension"}}, {"ref-fulltext": "Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ, Nonalcoholic Steatohepatitis Clinical Research N. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313-21.", "@id": "35", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "Design and validation of a histological scoring system for nonalcoholic fatty liver disease"}, "refd-itemidlist": {"itemid": {"$": "20044374023", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "41"}, "pagerange": {"@first": "1313", "@last": "1321"}}, "ref-text": "Nonalcoholic Steatohepatitis Clinical Research N 15915461", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.E.", "@_fa": "true", "ce:surname": "Kleiner", "ce:indexed-name": "Kleiner D.E."}, {"@seq": "2", "ce:initials": "E.M.", "@_fa": "true", "ce:surname": "Brunt", "ce:indexed-name": "Brunt E.M."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Van Natta", "ce:indexed-name": "Van Natta M."}, {"@seq": "4", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Behling", "ce:indexed-name": "Behling C."}, {"@seq": "5", "ce:initials": "M.J.", "@_fa": "true", "ce:surname": "Contos", "ce:indexed-name": "Contos M.J."}, {"@seq": "6", "ce:initials": "O.W.", "@_fa": "true", "ce:surname": "Cummings", "ce:indexed-name": "Cummings O.W."}, {"@seq": "7", "ce:initials": "L.D.", "@_fa": "true", "ce:surname": "Ferrell", "ce:indexed-name": "Ferrell L.D."}, {"@seq": "8", "ce:initials": "Y.C.", "@_fa": "true", "ce:surname": "Liu", "ce:indexed-name": "Liu Y.C."}, {"@seq": "9", "ce:initials": "M.S.", "@_fa": "true", "ce:surname": "Torbenson", "ce:indexed-name": "Torbenson M.S."}, {"@seq": "10", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Unalp-Arida", "ce:indexed-name": "Unalp-Arida A."}, {"@seq": "11", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Yeh", "ce:indexed-name": "Yeh M."}, {"@seq": "12", "ce:initials": "A.J.", "@_fa": "true", "ce:surname": "McCullough", "ce:indexed-name": "McCullough A.J."}, {"@seq": "13", "ce:initials": "A.J.", "@_fa": "true", "ce:surname": "Sanyal", "ce:indexed-name": "Sanyal A.J."}]}, "ref-sourcetitle": "Hepatology"}}, {"ref-fulltext": "Ballestri S, Zona S, Targher G, Romagnoli D, Baldelli E, Nascimbeni F, Roverato A, Guaraldi G, Lonardo A. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type two diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. J Gastroenterol Hepatol. 2016;31:936-44.", "@id": "36", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-title": {"ref-titletext": "Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type two diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis"}, "refd-itemidlist": {"itemid": {"$": "84964510429", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "31"}, "pagerange": {"@first": "936", "@last": "944"}}, "ref-text": "26667191", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Ballestri", "ce:indexed-name": "Ballestri S."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Zona", "ce:indexed-name": "Zona S."}, {"@seq": "3", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Targher", "ce:indexed-name": "Targher G."}, {"@seq": "4", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Romagnoli", "ce:indexed-name": "Romagnoli D."}, {"@seq": "5", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Baldelli", "ce:indexed-name": "Baldelli E."}, {"@seq": "6", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Nascimbeni", "ce:indexed-name": "Nascimbeni F."}, {"@seq": "7", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Roverato", "ce:indexed-name": "Roverato A."}, {"@seq": "8", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Guaraldi", "ce:indexed-name": "Guaraldi G."}, {"@seq": "9", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Lonardo", "ce:indexed-name": "Lonardo A."}]}, "ref-sourcetitle": "J Gastroenterol Hepatol"}}, {"ref-fulltext": "Ballestri S, Nascimbeni F, Romagnoli D, Lonardo A. The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment. Hepatol Res. 2016;46:1074-87.", "@id": "37", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-title": {"ref-titletext": "The independent predictors of non-alcoholic steatohepatitis and its individual histological features : Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment"}, "refd-itemidlist": {"itemid": {"$": "84993675348", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "46"}, "pagerange": {"@first": "1074", "@last": "1087"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Ballestri", "ce:indexed-name": "Ballestri S."}, {"@seq": "2", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Nascimbeni", "ce:indexed-name": "Nascimbeni F."}, {"@seq": "3", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Romagnoli", "ce:indexed-name": "Romagnoli D."}, {"@seq": "4", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Lonardo", "ce:indexed-name": "Lonardo A."}]}, "ref-sourcetitle": "Hepatol Res"}}, {"ref-fulltext": "Softic S, Cohen DE, Kahn CR. Role of dietary fructose and hepatic De novo lipogenesis in fatty liver disease. Dig Dis Sci. 2016;61:1282-93.", "@id": "38", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-title": {"ref-titletext": "Role of dietary fructose and hepatic De novo lipogenesis in fatty liver disease"}, "refd-itemidlist": {"itemid": {"$": "84957706228", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "61"}, "pagerange": {"@first": "1282", "@last": "1293"}}, "ref-text": "26856717", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Softic", "ce:indexed-name": "Softic S."}, {"@seq": "2", "ce:initials": "D.E.", "@_fa": "true", "ce:surname": "Cohen", "ce:indexed-name": "Cohen D.E."}, {"@seq": "3", "ce:initials": "C.R.", "@_fa": "true", "ce:surname": "Kahn", "ce:indexed-name": "Kahn C.R."}]}, "ref-sourcetitle": "Dig Dis Sci"}}, {"ref-fulltext": "Than NN, Newsome PN. A concise review of non-alcoholic fatty liver disease. Atherosclerosis. 2015;239:192-202.", "@id": "39", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "A concise review of non-alcoholic fatty liver disease"}, "refd-itemidlist": {"itemid": {"$": "84922622191", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "239"}, "pagerange": {"@first": "192", "@last": "202"}}, "ref-text": "25617860", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "N.N.", "@_fa": "true", "ce:surname": "Than", "ce:indexed-name": "Than N.N."}, {"@seq": "2", "ce:initials": "P.N.", "@_fa": "true", "ce:surname": "Newsome", "ce:indexed-name": "Newsome P.N."}]}, "ref-sourcetitle": "Atherosclerosis"}}, {"ref-fulltext": "Chang CJ, Tzeng TF, Liou SS, Chang YS, Liu IM. Kaempferol regulates the lipid-profile in high-fat diet-fed rats through an increase in hepatic PPARalpha levels. Planta Med. 2011;77:1876-82.", "@id": "40", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Kaempferol regulates the lipid-profile in high-fat diet-fed rats through an increase in hepatic PPARalpha levels"}, "refd-itemidlist": {"itemid": {"$": "82155197195", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "77"}, "pagerange": {"@first": "1876", "@last": "1882"}}, "ref-text": "21728151", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.J.", "@_fa": "true", "ce:surname": "Chang", "ce:indexed-name": "Chang C.J."}, {"@seq": "2", "ce:initials": "T.F.", "@_fa": "true", "ce:surname": "Tzeng", "ce:indexed-name": "Tzeng T.F."}, {"@seq": "3", "ce:initials": "S.S.", "@_fa": "true", "ce:surname": "Liou", "ce:indexed-name": "Liou S.S."}, {"@seq": "4", "ce:initials": "Y.S.", "@_fa": "true", "ce:surname": "Chang", "ce:indexed-name": "Chang Y.S."}, {"@seq": "5", "ce:initials": "I.M.", "@_fa": "true", "ce:surname": "Liu", "ce:indexed-name": "Liu I.M."}]}, "ref-sourcetitle": "Planta Med"}}, {"ref-fulltext": "Schuck S, Honsho M, Ekroos K, Shevchenko A, Simons K. Resistance of cell membranes to different detergents. Proc Natl Acad Sci U S A. 2003;100:5795-800.", "@id": "41", "ref-info": {"ref-publicationyear": {"@first": "2003"}, "ref-title": {"ref-titletext": "Resistance of cell membranes to different detergents"}, "refd-itemidlist": {"itemid": {"$": "0037947828", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "100"}, "pagerange": {"@first": "5795", "@last": "5800"}}, "ref-text": "12721375 156280", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Schuck", "ce:indexed-name": "Schuck S."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Honsho", "ce:indexed-name": "Honsho M."}, {"@seq": "3", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Ekroos", "ce:indexed-name": "Ekroos K."}, {"@seq": "4", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Shevchenko", "ce:indexed-name": "Shevchenko A."}, {"@seq": "5", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Simons", "ce:indexed-name": "Simons K."}]}, "ref-sourcetitle": "Proc Natl Acad Sci U S A"}}, {"ref-fulltext": "Wang L, Chen K, Liu K, Zhou Y, Zhang T, Wang B, Mi M. DHA inhibited AGEs-induced retinal microglia activation via suppression of the PPARgamma/NFkappaB pathway and reduction of signal transducers in the AGEs/RAGE axis recruitment into lipid rafts. Neurochem Res. 2015;40:713-22.", "@id": "42", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "DHA inhibited AGEs-induced retinal microglia activation via suppression of the PPARgamma/NFkappaB pathway and reduction of signal transducers in the AGEs/RAGE axis recruitment into lipid rafts"}, "refd-itemidlist": {"itemid": {"$": "84939986934", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "40"}, "pagerange": {"@first": "713", "@last": "722"}}, "ref-text": "25596942", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Wang", "ce:indexed-name": "Wang L."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Chen", "ce:indexed-name": "Chen K."}, {"@seq": "3", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Liu", "ce:indexed-name": "Liu K."}, {"@seq": "4", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Zhou", "ce:indexed-name": "Zhou Y."}, {"@seq": "5", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Zhang", "ce:indexed-name": "Zhang T."}, {"@seq": "6", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Wang", "ce:indexed-name": "Wang B."}, {"@seq": "7", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Mi", "ce:indexed-name": "Mi M."}]}, "ref-sourcetitle": "Neurochem Res"}}, {"ref-fulltext": "Munesue S, Yamamoto Y, Urushihara R, Inomata K, Saito H, Motoyoshi S, Watanabe T, Yonekura H, Yamamoto H. Low-molecular weight fractions of Japanese soy sauce act as a RAGE antagonist via inhibition of RAGE trafficking to lipid rafts. Food Funct. 2013;4:1835-42.", "@id": "43", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Low-molecular weight fractions of Japanese soy sauce act as a RAGE antagonist via inhibition of RAGE trafficking to lipid rafts"}, "refd-itemidlist": {"itemid": {"$": "84888153013", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "4"}, "pagerange": {"@first": "1835", "@last": "1842"}}, "ref-text": "24191276", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Munesue", "ce:indexed-name": "Munesue S."}, {"@seq": "2", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Yamamoto", "ce:indexed-name": "Yamamoto Y."}, {"@seq": "3", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Urushihara", "ce:indexed-name": "Urushihara R."}, {"@seq": "4", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Inomata", "ce:indexed-name": "Inomata K."}, {"@seq": "5", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Saito", "ce:indexed-name": "Saito H."}, {"@seq": "6", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Motoyoshi", "ce:indexed-name": "Motoyoshi S."}, {"@seq": "7", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Watanabe", "ce:indexed-name": "Watanabe T."}, {"@seq": "8", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Yonekura", "ce:indexed-name": "Yonekura H."}, {"@seq": "9", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Yamamoto", "ce:indexed-name": "Yamamoto H."}]}, "ref-sourcetitle": "Food Funct"}}, {"ref-fulltext": "Chang Y, Jung HS, Cho J, Zhang Y, Yun KE, Lazo M, Pastor-Barriuso R, Ahn J, Kim CW, Rampal S, Cainzos-Achirica M, Zhao D, Chung EC, Shin H, Guallar E, Ryu S. Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease. Am J Gastroenterol. 2016;111:1133-40.", "@id": "44", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-title": {"ref-titletext": "Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease"}, "refd-itemidlist": {"itemid": {"$": "84982994828", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "111"}, "pagerange": {"@first": "1133", "@last": "1140"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Chang", "ce:indexed-name": "Chang Y."}, {"@seq": "2", "ce:initials": "H.S.", "@_fa": "true", "ce:surname": "Jung", "ce:indexed-name": "Jung H.S."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Cho", "ce:indexed-name": "Cho J."}, {"@seq": "4", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Zhang", "ce:indexed-name": "Zhang Y."}, {"@seq": "5", "ce:initials": "K.E.", "@_fa": "true", "ce:surname": "Yun", "ce:indexed-name": "Yun K.E."}, {"@seq": "6", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Lazo", "ce:indexed-name": "Lazo M."}, {"@seq": "7", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Pastor-Barriuso", "ce:indexed-name": "Pastor-Barriuso R."}, {"@seq": "8", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Ahn", "ce:indexed-name": "Ahn J."}, {"@seq": "9", "ce:initials": "C.W.", "@_fa": "true", "ce:surname": "Kim", "ce:indexed-name": "Kim C.W."}, {"@seq": "10", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Rampal", "ce:indexed-name": "Rampal S."}, {"@seq": "11", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Cainzos-Achirica", "ce:indexed-name": "Cainzos-Achirica M."}, {"@seq": "12", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Zhao", "ce:indexed-name": "Zhao D."}, {"@seq": "13", "ce:initials": "E.C.", "@_fa": "true", "ce:surname": "Chung", "ce:indexed-name": "Chung E.C."}, {"@seq": "14", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Shin", "ce:indexed-name": "Shin H."}, {"@seq": "15", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Guallar", "ce:indexed-name": "Guallar E."}, {"@seq": "16", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Ryu", "ce:indexed-name": "Ryu S."}]}, "ref-sourcetitle": "Am J Gastroenterol"}}, {"ref-fulltext": "Shahataa MG, Mostafa-Hedeab G, Ali EF, Mahdi EA, Mahmoud FA. Effects of telmisartan and pioglitazone on high fructose induced metabolic syndrome in rats. Can J Physiol Pharmacol. 2016;94:907-17.", "@id": "45", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-title": {"ref-titletext": "Effects of telmisartan and pioglitazone on high fructose induced metabolic syndrome in rats"}, "refd-itemidlist": {"itemid": {"$": "84979994195", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "94"}, "pagerange": {"@first": "907", "@last": "917"}}, "ref-text": "27245695", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.G.", "@_fa": "true", "ce:surname": "Shahataa", "ce:indexed-name": "Shahataa M.G."}, {"@seq": "2", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Mostafa-Hedeab", "ce:indexed-name": "Mostafa-Hedeab G."}, {"@seq": "3", "ce:initials": "E.F.", "@_fa": "true", "ce:surname": "Ali", "ce:indexed-name": "Ali E.F."}, {"@seq": "4", "ce:initials": "E.A.", "@_fa": "true", "ce:surname": "Mahdi", "ce:indexed-name": "Mahdi E.A."}, {"@seq": "5", "ce:initials": "F.A.", "@_fa": "true", "ce:surname": "Mahmoud", "ce:indexed-name": "Mahmoud F.A."}]}, "ref-sourcetitle": "Can J Physiol Pharmacol"}}, {"ref-fulltext": "Collino M, Aragno M, Castiglia S, Miglio G, Tomasinelli C, Boccuzzi G, Thiemermann C, Fantozzi R. Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation. Br J Pharmacol. 2010;160:1892-902.", "@id": "46", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation"}, "refd-itemidlist": {"itemid": {"$": "77954880936", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "160"}, "pagerange": {"@first": "1892", "@last": "1902"}}, "ref-text": "20233219 2958635", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Collino", "ce:indexed-name": "Collino M."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Aragno", "ce:indexed-name": "Aragno M."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Castiglia", "ce:indexed-name": "Castiglia S."}, {"@seq": "4", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Miglio", "ce:indexed-name": "Miglio G."}, {"@seq": "5", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Tomasinelli", "ce:indexed-name": "Tomasinelli C."}, {"@seq": "6", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Boccuzzi", "ce:indexed-name": "Boccuzzi G."}, {"@seq": "7", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Thiemermann", "ce:indexed-name": "Thiemermann C."}, {"@seq": "8", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Fantozzi", "ce:indexed-name": "Fantozzi R."}]}, "ref-sourcetitle": "Br J Pharmacol"}}, {"ref-fulltext": "Kong X, Zhang DY, Wu HB, Li FX. Losartan and pioglitazone ameliorate nephropathy in experimental metabolic syndrome rats. Biol Pharm Bull. 2011;34:693-9.", "@id": "47", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Losartan and pioglitazone ameliorate nephropathy in experimental metabolic syndrome rats"}, "refd-itemidlist": {"itemid": {"$": "79955645297", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "34"}, "pagerange": {"@first": "693", "@last": "699"}}, "ref-text": "21532159", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "X.", "@_fa": "true", "ce:surname": "Kong", "ce:indexed-name": "Kong X."}, {"@seq": "2", "ce:initials": "D.Y.", "@_fa": "true", "ce:surname": "Zhang", "ce:indexed-name": "Zhang D.Y."}, {"@seq": "3", "ce:initials": "H.B.", "@_fa": "true", "ce:surname": "Wu", "ce:indexed-name": "Wu H.B."}, {"@seq": "4", "ce:initials": "F.X.", "@_fa": "true", "ce:surname": "Li", "ce:indexed-name": "Li F.X."}]}, "ref-sourcetitle": "Biol Pharm Bull"}}, {"ref-fulltext": "Ackerman Z, Oron-Herman M, Pappo O, Peleg E, Safadi R, Schmilovitz-Weiss H, Grozovski M. Hepatic effects of rosiglitazone in rats with the metabolic syndrome. Basic Clin Pharmacol Toxicol. 2010;107:663-8.", "@id": "48", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Hepatic effects of rosiglitazone in rats with the metabolic syndrome"}, "refd-itemidlist": {"itemid": {"$": "77954710226", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "107"}, "pagerange": {"@first": "663", "@last": "668"}}, "ref-text": "20210788", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Z.", "@_fa": "true", "ce:surname": "Ackerman", "ce:indexed-name": "Ackerman Z."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Oron-Herman", "ce:indexed-name": "Oron-Herman M."}, {"@seq": "3", "ce:initials": "O.", "@_fa": "true", "ce:surname": "Pappo", "ce:indexed-name": "Pappo O."}, {"@seq": "4", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Peleg", "ce:indexed-name": "Peleg E."}, {"@seq": "5", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Safadi", "ce:indexed-name": "Safadi R."}, {"@seq": "6", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Schmilovitz-Weiss", "ce:indexed-name": "Schmilovitz-Weiss H."}, {"@seq": "7", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Grozovski", "ce:indexed-name": "Grozovski M."}]}, "ref-sourcetitle": "Basic Clin Pharmacol Toxicol"}}, {"ref-fulltext": "Schalkwijk CG, Stehouwer CD, van Hinsbergh VW. Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification. Diabetes Metab Res Rev. 2004;20:369-82.", "@id": "49", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification"}, "refd-itemidlist": {"itemid": {"$": "4644271610", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "20"}, "pagerange": {"@first": "369", "@last": "382"}}, "ref-text": "15343583", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.G.", "@_fa": "true", "ce:surname": "Schalkwijk", "ce:indexed-name": "Schalkwijk C.G."}, {"@seq": "2", "ce:initials": "C.D.", "@_fa": "true", "ce:surname": "Stehouwer", "ce:indexed-name": "Stehouwer C.D."}, {"@seq": "3", "ce:initials": "V.W.", "@_fa": "true", "ce:surname": "Van Hinsbergh", "ce:indexed-name": "Van Hinsbergh V.W."}]}, "ref-sourcetitle": "Diabetes Metab Res Rev"}}, {"ref-fulltext": "Kumagai T, Matsukawa N, Kaneko Y, Kusumi Y, Mitsumata M, Uchida K. A lipid peroxidation-derived inflammatory mediator: identification of 4-hydroxy-2-nonenal as a potential inducer of cyclooxygenase-2 in macrophages. J Biol Chem. 2004;279:48389-96.", "@id": "50", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "A lipid peroxidation-derived inflammatory mediator: identification of 4-hydroxy-2-nonenal as a potential inducer of cyclooxygenase-2 in macrophages"}, "refd-itemidlist": {"itemid": {"$": "9144219652", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "279"}, "pagerange": {"@first": "48389", "@last": "48396"}}, "ref-text": "15355999", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Kumagai", "ce:indexed-name": "Kumagai T."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Matsukawa", "ce:indexed-name": "Matsukawa N."}, {"@seq": "3", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Kaneko", "ce:indexed-name": "Kaneko Y."}, {"@seq": "4", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Kusumi", "ce:indexed-name": "Kusumi Y."}, {"@seq": "5", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Mitsumata", "ce:indexed-name": "Mitsumata M."}, {"@seq": "6", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Uchida", "ce:indexed-name": "Uchida K."}]}, "ref-sourcetitle": "J Biol Chem"}}, {"ref-fulltext": "Kanauchi M, Tsujimoto N, Hashimoto T. Advanced glycation end products in nondiabetic patients with coronary artery disease. Diabetes Care. 2001;24:1620-3.", "@id": "51", "ref-info": {"ref-publicationyear": {"@first": "2001"}, "ref-title": {"ref-titletext": "Advanced glycation end products in nondiabetic patients with coronary artery disease"}, "refd-itemidlist": {"itemid": {"$": "0035458292", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "24"}, "pagerange": {"@first": "1620", "@last": "1623"}}, "ref-text": "11522709", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Kanauchi", "ce:indexed-name": "Kanauchi M."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Tsujimoto", "ce:indexed-name": "Tsujimoto N."}, {"@seq": "3", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Hashimoto", "ce:indexed-name": "Hashimoto T."}]}, "ref-sourcetitle": "Diabetes Care"}}]}}}}, "affiliation": [{"affiliation-city": "Milan", "@id": "60030318", "affilname": "Universit\u00e0 degli Studi di Milano", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030318", "affiliation-country": "Italy"}, {"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, {"affiliation-city": "Bangkok", "@id": "60002620", "affilname": "Faculty of Medicine, Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620", "affiliation-country": "Thailand"}, {"affiliation-city": "Milan", "@id": "114289076", "affilname": "UOC Anatomia Patologica", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/114289076", "affiliation-country": "Italy"}], "coredata": {"srctype": "j", "eid": "2-s2.0-85010297712", "dc:description": "Background: The AGE-RAGE-oxidative stress (AROS) axis is involved in the onset and progression of metabolic syndrome induced by a high-fructose diet (HFD). PPAR\u03b3 activation is known to modulate metabolic syndrome; however a systems-level investigation looking at the protective effects of PPAR\u03b3 activation as related to the AROS axis has not been performed. The aim of this work is to simultaneously characterize multiple molecular parameters within the AROS axis, using samples taken from different body fluids and tissues of a rat model of HFD-induced metabolic syndrome, in the presence or absence of a PPAR\u03b3 agonist, Rosiglitazone (RGZ). Methods: Rats were fed with 60% HFD for the first half of the treatment duration (21 days) then continued with either HFD alone or HFD plus RGZ for the second half. Results: Rats receiving HFD alone showed metabolic syndrome manifestations including hypertension, dyslipidemia, increased glucose levels and insulin resistance, as well as abnormal kidney and inflammatory parameters. Systolic blood pressure, plasma triglyceride and glucose levels, plasma creatinine, and albuminuria were significantly improved in the presence of RGZ. The following molecular parameters of the AROS axis were significantly upregulated in our rat model: carboxymethyl lysine (CML) in urine and liver; carboxyethyl lysine (CEL) in urine; advanced glycation end products (AGEs) in plasma; receptor for advanced glycation end products (RAGE) in liver and kidney; advanced oxidation protein products (AOPP) in plasma; and 4-hydroxynonenal (HNE) in plasma, liver, and kidney. Conversely, with RGZ administration, the upregulation of AOPP and AGEs in plasma, CML and CEL in urine, RAGE in liver as well as HNE in plasma and liver was significantly counteracted/prevented. Conclusions: Our data demonstrate (i) the systems-level regulatory landscape of HFD-induced metabolic syndrome involving multiple molecular parameters, including HNE, AGEs and their receptor RAGE, and (ii) attenuation of metabolic syndrome by PPAR\u03b3 modulation.", "prism:coverDate": "2017-01-13", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85010297712", "dc:creator": {"author": [{"ce:given-name": "Luca", "preferred-name": {"ce:given-name": "Luca", "ce:initials": "L.", "ce:surname": "Cannizzaro", "ce:indexed-name": "Cannizzaro L."}, "@seq": "1", "ce:initials": "L.", "@_fa": "true", "affiliation": [{"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, {"@id": "60030318", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030318"}], "ce:surname": "Cannizzaro", "@auid": "56809020400", "author-url": "https://api.elsevier.com/content/author/author_id/56809020400", "ce:indexed-name": "Cannizzaro L."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/85010297712"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85010297712&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85010297712&origin=inward"}], "source-id": "15300154824", "citedby-count": "31", "prism:volume": "14", "subtype": "ar", "dc:title": "Regulatory landscape of AGE-RAGE-oxidative stress axis and its modulation by PPAR\u03b3 activation in high fructose diet-induced metabolic syndrome", "openaccess": "1", "prism:issn": "17437075", "publishercopyright": "\u00a9 2017 The Author(s).", "prism:issueIdentifier": "1", "subtypeDescription": "Article", "prism:publicationName": "Nutrition and Metabolism", "prism:pageRange": "1-13", "prism:endingPage": "13", "openaccessFlag": "true", "prism:doi": "10.1186/s12986-016-0149-z", "prism:startingPage": "1", "dc:identifier": "SCOPUS_ID:85010297712", "dc:publisher": "BioMed Central Ltd.info@biomedcentral.com"}, "idxterms": null, "language": {"@xml:lang": "eng"}, "authkeywords": {"author-keyword": [{"@_fa": "true", "$": "AGE-RAGE-oxidative stress axis"}, {"@_fa": "true", "$": "Fructose"}, {"@_fa": "true", "$": "HNE"}, {"@_fa": "true", "$": "Metabolic syndrome"}, {"@_fa": "true", "$": "PPAR\u03b3"}, {"@_fa": "true", "$": "Rosiglitazone"}]}, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Medicine (miscellaneous)", "@code": "2701", "@abbrev": "MEDI"}, {"@_fa": "true", "$": "Endocrinology, Diabetes and Metabolism", "@code": "2712", "@abbrev": "MEDI"}, {"@_fa": "true", "$": "Nutrition and Dietetics", "@code": "2916", "@abbrev": "NURS"}]}, "authors": {"author": [{"ce:given-name": "Luca", "preferred-name": {"ce:given-name": "Luca", "ce:initials": "L.", "ce:surname": "Cannizzaro", "ce:indexed-name": "Cannizzaro L."}, "@seq": "1", "ce:initials": "L.", "@_fa": "true", "affiliation": [{"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, {"@id": "60030318", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030318"}], "ce:surname": "Cannizzaro", "@auid": "56809020400", "author-url": "https://api.elsevier.com/content/author/author_id/56809020400", "ce:indexed-name": "Cannizzaro L."}, {"ce:given-name": "Giuseppe", "preferred-name": {"ce:given-name": "Giuseppe", "ce:initials": "G.", "ce:surname": "Rossoni", "ce:indexed-name": "Rossoni G."}, "@seq": "2", "ce:initials": "G.", "@_fa": "true", "affiliation": {"@id": "60030318", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030318"}, "ce:surname": "Rossoni", "@auid": "7006372950", "author-url": "https://api.elsevier.com/content/author/author_id/7006372950", "ce:indexed-name": "Rossoni G."}, {"ce:given-name": "Federica", "preferred-name": {"ce:given-name": "Federica", "ce:initials": "F.", "ce:surname": "Savi", "ce:indexed-name": "Savi F."}, "@seq": "3", "ce:initials": "F.", "@_fa": "true", "affiliation": {"@id": "114289076", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/114289076"}, "ce:surname": "Savi", "@auid": "11339836500", "author-url": "https://api.elsevier.com/content/author/author_id/11339836500", "ce:indexed-name": "Savi F."}, {"ce:given-name": "Alessandra", "preferred-name": {"ce:given-name": "Alessandra", "ce:initials": "A.", "ce:surname": "Altomare", "ce:indexed-name": "Altomare A."}, "@seq": "4", "ce:initials": "A.", "@_fa": "true", "affiliation": {"@id": "60030318", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030318"}, "ce:surname": "Altomare", "@auid": "55587251500", "author-url": "https://api.elsevier.com/content/author/author_id/55587251500", "ce:indexed-name": "Altomare A."}, {"ce:given-name": "Cristina", "preferred-name": {"ce:given-name": "Cristina", "ce:initials": "C.", "ce:surname": "Marinello", "ce:indexed-name": "Marinello C."}, "@seq": "5", "ce:initials": "C.", "@_fa": "true", "affiliation": {"@id": "60030318", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030318"}, "ce:surname": "Marinello", "@auid": "7006556911", "author-url": "https://api.elsevier.com/content/author/author_id/7006556911", "ce:indexed-name": "Marinello C."}, {"ce:given-name": "Thammakorn", "preferred-name": {"ce:given-name": "Thammakorn", "ce:initials": "T.", "ce:surname": "Saethang", "ce:indexed-name": "Saethang T."}, "@seq": "6", "ce:initials": "T.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Saethang", "@auid": "35073059200", "author-url": "https://api.elsevier.com/content/author/author_id/35073059200", "ce:indexed-name": "Saethang T."}, {"ce:given-name": "Marina", "preferred-name": {"ce:given-name": "Marina", "ce:initials": "M.", "ce:surname": "Carini", "ce:indexed-name": "Carini M."}, "@seq": "7", "ce:initials": "M.", "@_fa": "true", "affiliation": {"@id": "60030318", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030318"}, "ce:surname": "Carini", "@auid": "56271103700", "author-url": "https://api.elsevier.com/content/author/author_id/56271103700", "ce:indexed-name": "Carini M."}, {"ce:given-name": "D. Michael", "preferred-name": {"ce:given-name": "D. Michael", "ce:initials": "D.M.", "ce:surname": "Payne", "ce:indexed-name": "Payne D.M."}, "@seq": "8", "ce:initials": "D.M.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Payne", "@auid": "7402805350", "author-url": "https://api.elsevier.com/content/author/author_id/7402805350", "ce:indexed-name": "Payne D.M."}, {"ce:given-name": "Trairak", "preferred-name": {"ce:given-name": "Trairak", "ce:initials": "T.", "ce:surname": "Pisitkun", "ce:indexed-name": "Pisitkun T."}, "@seq": "9", "ce:initials": "T.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Pisitkun", "@auid": "6507728111", "author-url": "https://api.elsevier.com/content/author/author_id/6507728111", "ce:indexed-name": "Pisitkun T."}, {"ce:given-name": "Giancarlo", "preferred-name": {"ce:given-name": "Giancarlo", "ce:initials": "G.", "ce:surname": "Aldini", "ce:indexed-name": "Aldini G."}, "@seq": "10", "ce:initials": "G.", "@_fa": "true", "affiliation": {"@id": "60030318", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030318"}, "ce:surname": "Aldini", "@auid": "7003627860", "author-url": "https://api.elsevier.com/content/author/author_id/7003627860", "ce:indexed-name": "Aldini G."}, {"ce:given-name": "Asada", "preferred-name": {"ce:given-name": "Asada", "ce:initials": "A.", "ce:surname": "Leelahavanichkul", "ce:indexed-name": "Leelahavanichkul A."}, "@seq": "11", "ce:initials": "A.", "@_fa": "true", "affiliation": {"@id": "60002620", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"}, "ce:surname": "Leelahavanichkul", "@auid": "24587653600", "author-url": "https://api.elsevier.com/content/author/author_id/24587653600", "ce:indexed-name": "Leelahavanichkul A."}]}}}